#BIO22: De­cen­tral­ized tri­als

Zachary Bren­nan:

Hel­lo. Good morn­ing. I’m Zachary Bren­nan, se­nior ed­i­tor at End­points News. And thank you for join­ing us vir­tu­al­ly at BIO for our pan­el on de­cen­tral­ized tri­als. Join­ing me to­day, we have Ro­nan Brown, Se­nior Vice Pres­i­dent of IQVIA, Craig Lipset, founder of Clin­i­cal In­no­va­tion Part­ners, and Bari Kow­al, se­nior vice pres­i­dent of Re­gen­eron. I’m ex­cit­ed for to­day’s dis­cus­sion and I’m sure you are too, but be­fore we get in­to it, we have a brief word from Vice Pres­i­dent Matt Blume with to­day’s spon­sor, Catal­ent.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER